{"product_id":"9781461288886-risk-benefit-analysis-for-the-use-and-ap","title":"Risk\/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents","description":"\u003cmeta content=\"text\/html; charset=utf-8\" http-equiv=\"Content-Type\"\u003e\u003cp\u003e\u003cspan\u003eProceedings of the Ninth Annual Symposium on New Drugs \u0026amp; Devices, October 27 \u0026amp; 28, 1988\u003cbr\u003eThe Ninth Annual symposium on New Drugs addressed the problem of determining the risk versus benefit for use of three important classes of cardiovascular agents: thrombolytic, antiarrhythmic, and hypolipidemic agents.\u003cbr\u003e\u003cbr\u003e\u003c\/span\u003e\u003c\/p\u003e","brand":"Rarewaves","offers":[{"title":"Default Title","offer_id":56700087370102,"sku":"9781461288886","price":208.48,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0092\/7504\/8033\/files\/stand_38792502.jpg?v=1764387814","url":"https:\/\/www.rarewaves.com\/products\/9781461288886-risk-benefit-analysis-for-the-use-and-ap","provider":"Rarewaves.com","version":"1.0","type":"link"}